Charles-Antoine Janssen

Serves on the board of the following private companies: Regency Hospitals, Medikabazaar, THB, Lilac Insights, TC4AI and on the Advisory Board of Lighthouse (India PE fund) and Quadria (Asia healthcare PE fund).

Worked for Merrill Lynch in London from 1996-2000 where he was Vice President of Equities Research, and then Vice President of New Derivatives, Europe. In 2001, Charles joined UCB as Head of Global Business Development. Following the acquisition of Celltech, Charles moved to operations in 2005 as General Manager of Austria, then India. From 2010-2012, he managed International Major Markets Operations. He joined the board of Tubize in 2011, the board of UCB in 2012 and UCB’s Audit Committee in 2015.

He holds a bachelor of laws degree from Brussels University and completed the Advanced Management Program of Harvard Business School. Until his 2016 move to India, Charles was Assistant Professor of social entrepreneurship at the Solvay Brussels School of Management and Economics (ULB, Brussels University). Charles is a member of the Board of Fellows of Stanford School of Medicine.